Literature DB >> 7892420

Atropine effects on the intermediate stage and paradoxical sleep in rats.

C Arnaud1, P Gauthier, C Gottesmann.   

Abstract

Paradoxical sleep (PS) in the rat, cat and mouse is preceded and sometimes followed by a short-lasting intermediate stage (IS) characterized by high amplitude cortical spindles and low frequency theta rhythm. This stage, which is mimicked by an intercollicular transection, is massively extended at the expense of PS by low doses of barbiturates. Since the pontine cholinergic cell activation of PS is suppressed by barbiturates, we studied whether atropine, an antimuscarinic compound, extends IS at the expense of PS. Atropine sulfate was given at 5, 10 and 20 mg/kg IP. All doses increased dose dependently the occurrence latency of IS and PS. The amount of IS and PS was decreased for several hours, principally by a decrease of the number of phases. At 20 mg/kg the phase mean duration of IS and PS was also decreased. Consequently, IS and PS are similarly supported by muscarinic processes. The theta rhythm frequency was scored during IS and outside PS phasic motor activities (type 2 theta). At all doses it was significantly increased for hours. The theta rhythm frequency was also transiently increased during the hypersynchronization periods of PS (type 1 theta). At 20 mg/kg it was similarly the case for type 1 theta rhythm during waking.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892420     DOI: 10.1007/bf02245333

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  [Specific & non-specific facilitations of cortical visual responses].

Authors:  S DUMONT; P DELL
Journal:  J Physiol (Paris)       Date:  1958-03

2.  M1 and M3 muscarinic receptors: specific roles in sleep regulation.

Authors:  L Imeri; S Bianchi; P Angeli; M Mancia
Journal:  Neuroreport       Date:  1992-03       Impact factor: 1.837

3.  Hippocampal electrical activity during waking behaviour and sleep: analyses using centrally acting drugs.

Authors:  C H Vanderwolf; R Kramis; T E Robinson
Journal:  Ciba Found Symp       Date:  1977

4.  Pharmacological dissociation of EEG and behavior: a basic problem in sleep-wake classification.

Authors:  A M Coenen; E L van Luijtelaar
Journal:  Sleep       Date:  1991-10       Impact factor: 5.849

5.  Neocortical and hippocampal activation relation to behavior: effects of atropine, eserine, phenothiazines, and amphetamine.

Authors:  C H Vanderwolf
Journal:  J Comp Physiol Psychol       Date:  1975-01

Review 6.  The physiology and pharmacology of hippocampal formation theta rhythms.

Authors:  B H Bland
Journal:  Prog Neurobiol       Date:  1986       Impact factor: 11.685

7.  Transmission processes in the ventrobasal complex of rat during the sleep-waking cycle.

Authors:  G Gandolfo; C Arnaud; C Gottesmann
Journal:  Brain Res Bull       Date:  1980 Sep-Oct       Impact factor: 4.077

8.  Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle.

Authors:  G Aston-Jones; F E Bloom
Journal:  J Neurosci       Date:  1981-08       Impact factor: 6.167

9.  The intermediate stage of sleep in mice.

Authors:  L Glin; C Arnaud; D Berracochea; D Galey; R Jaffard; C Gottesmann
Journal:  Physiol Behav       Date:  1991-11

10.  Pontine neuronal response to local cholinergic infusion: relation to REM sleep.

Authors:  P J Shiromani; D J McGinty
Journal:  Brain Res       Date:  1986-10-29       Impact factor: 3.252

View more
  2 in total

1.  Different Simultaneous Sleep States in the Hippocampus and Neocortex.

Authors:  Joshua J Emrick; Brooks A Gross; Brett T Riley; Gina R Poe
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

2.  Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathology.

Authors:  Korey Kam; Áine M Duffy; Jillian Moretto; John J LaFrancois; Helen E Scharfman
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.